Specifically, the money will help the privately held company pay for further development of its LEAP-enabled LaserFect technology for high-efficiency, low-toxicity delivery of siRNA into cells "that are typically refractory to standard transfection techniques."
The award comes 10 months after Cyntellect won $500,000 in a Phase II SBIR grant to develop the laser-based transfection technology, and the fifth the company has received since July 2003, RNAi News, GenomeWeb News' sister publication, reported in November.